Alembic Pharma gets final nod from USFDA for generic drug to treat Parkinson's disease

The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Entacapone tablets is for strength of 200 mg, the company said in a regulatory filing. It is therapeutically equivalent to the reference listed drug product (RLD) Comtan tablets, 200 mg, of Orion Corporation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3F1ToIO
via IFTTT